Scientists map liver degeneration at the cellular level
NCT ID NCT07265544
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand how liver diseases like fatty liver, hepatitis B, fibrosis, and cirrhosis develop by analyzing individual liver cells and their spatial organization. Researchers will collect blood and discarded liver tissue from 240 patients undergoing surgery or biopsy. The goal is to identify new targets for future treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATTY LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nan
RECRUITINGGuangzhou, Guangdong, 510515, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can extra doses of an old drug reverse liver scarring?
- Can smarter surgical tools cut liver surgery risks?
- Can Weight-Loss surgery beat drugs for advanced liver damage?
- HIV and fatty liver: a hidden link under the microscope
- 10-Year quest to uncover fatty Liver's hidden toll in china
- Navy beans take on fatty liver: a diet swap put to the test